hepatitis b
Cipla Launches Hepatitis B Vaccine In India
Cipla's hepatitis B vaccine can prevent 95 percent of the recipients from developing a chronic infection, protecting them for decades.
Protecting Children Receiving Liver Transplants From HepB
The ability to prevent recipients from developing hepatitis B from donated livers could increase the donor pool.
HBV Exposure Matures Infants’ Immune Systems
Exposure to HBV in the womb could help to train the immune system of babies, according to study.
Hot On The Trail Of The Hepatitis-Liver Cancer Connection
Infection with hepatitis viruses leads to the same genetic profile in tumors, even if they look different histologically.
7 Must-Read Stories In January 2015
Whether its a new way to fold DNA or a map of the TB bacteria proteome, these technological advancements are likely to enable further research in the year ahead.
BMS Foundation Awards US$3.5 Million In Hepatitis Grants
Bristol-Myers Squibb has awarded US$3.5 million in grants to tackle the 'silent epidemic' of hepatitis in India and China.
Neonatal HBV Vaccination Reduces Liver Cancer Risk
A follow-up study spanning 30 years shows that vaccinating babies against HBV reduces their risk of liver disease in adulthood.
Gilead Allows India & China To Produce Generic HIV/HBV Drug
An agreement with the Medicines Patent Pool allows generics manufacturers in India and China to produce Gilead's HBV and HIV drug, tenofovir alafenamide.
Antivirals Reduce Liver Disease Risk
Two independent studies show that treating hepatitis B early with antiviral drugs can reduce the risk of developing liver disease.
